--- title: "TOVX.US (TOVX.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/TOVX.US/news.md" symbol: "TOVX.US" name: "TOVX.US" parent: "https://longbridge.com/en/quote/TOVX.US.md" datetime: "2026-05-21T18:33:57.500Z" locales: - [en](https://longbridge.com/en/quote/TOVX.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/TOVX.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/TOVX.US/news.md) --- # TOVX.US (TOVX.US) — Related News ### [Alliance Global Partners Sticks to Its Buy Rating for Theriva Biologics (TOVX)](https://longbridge.com/en/news/285369266.md) *2026-05-06T11:38:27.000Z* > Alliance Global Partners has maintained a Buy rating for Theriva Biologics (TOVX) with a price target of $4.00, accordin ### [Theriva Q1 Net Loss Narrows; Plans Dosing Feasibility Study Of VCN-01 In H2,2026;Stock Down](https://longbridge.com/en/news/285347619.md) *2026-05-06T09:35:16.000Z* > Theriva Biologics, Inc. (TOVX) reported a narrower net loss of $2.04 million for Q1 2026, down from $4.32 million the pr ### [Theriva Biologics | 8-K: FY2026 Q1 Revenue: USD 300 K](https://longbridge.com/en/news/285265487.md) *2026-05-05T20:47:17.000Z* ### [Valerio Therapeutics Announces the Launch of InVimmune, a New Company Dedicated to Developing Differentiated in Vivo Cell Therapy Approaches](https://longbridge.com/en/news/285037962.md) *2026-05-04T07:05:31.000Z* > Valerio Therapeutics has launched InVimmune, a new company focused on developing differentiated in vivo cell therapy app ### [3 Penny Stocks to Watch Now, 4/21/26](https://longbridge.com/en/news/283540118.md) *2026-04-21T17:19:08.000Z* > Three penny stocks to watch on April 21 are Enveric Biosciences (ENVB), Psyence Biomedical (PBM), and Theriva Biologics ### [U.S. stock market midday update: Theriva Biologics stock price plummets 23.22%, market reacts lukewarm to clinical trial data?](https://longbridge.com/en/news/283515547.md) *2026-04-21T14:03:23.000Z* > Theriva Biologics fell 23.22%; AbbVie fell 0.27%, with a transaction volume of USD 322 million; Alnylam Pharmaceuticals ### [12 Health Care Stocks Moving In Tuesday's Pre-Market Session](https://longbridge.com/en/news/283498352.md) *2026-04-21T12:05:49.000Z* > In Tuesday's pre-market session, several health care stocks experienced significant movements. Notable gainers included ### [Pre-market hot trades in US stocks: Aevex up 12.24% pre-market; Theriva Biologics down 11.78% pre-market](https://longbridge.com/en/news/283461789.md) *2026-04-21T08:28:03.000Z* > Aevex pre-market up 12.24%; Theriva Biologics pre-market down 11.78%; SciSparc pre-market up 70.69%; Baiya pre-market up ### [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://longbridge.com/en/news/283351039.md) *2026-04-20T12:05:50.000Z* > In Monday's pre-market session, several health care stocks experienced significant movements. Psyence Biomedical (PBM) s ### [12 Health Care Stocks Moving In Monday's Intraday Session](https://longbridge.com/en/news/283385887.md) *2026-04-20T17:05:50.000Z* > In Monday's intraday session, Enveric Biosciences (ENVB) saw a significant gain of 132.7%, reaching $4.24, while Psyence